Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Last update: Oct 29, 2026

Details

Location: EU 27
Contracting Authority: Horizon Europe (2021 - 2027)
Contracting Authority Type: Development Institution
Status: Open
Budget: EUR 44,200,000
Award ceiling: 8,000,000
Award floor: 6,000,000
Sector: Health, ICT & Telecommunications, Research & Innovation
Eligible applicants: Unrestricted / Unspecified
Eligible nationalities: Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Aruba, Austria, Azerbaijan, Bangladesh, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central African Republic, Chad, Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Curaçao, Cyprus, Czech Republic, Dem. Rep. Congo, Denmark, Djibouti, Dominica, Commonwealth of, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini (Swaziland), Ethiopia, Faroe Islands, Fiji, Finland, France, French Polynesia, French Southern Territory, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Micronesia, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Korea, North Macedonia, Norway, Pakistan, Palau, Palestine / West Bank & Gaza, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Rwanda, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Senegal, Serbia, Sierra Leone, Sint Maarten, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Korea, South Sudan, Spain, Sri Lanka, St. Pierre and Miquelon, Sudan, Suriname, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Türkiye, Turkmenistan, Tuvalu, Uganda, UK, Ukraine, Uzbekistan, Vanuatu, Venezuela, Vietnam, Wallis and Futuna, Yemen, Zambia, Zimbabwe
Date posted: Dec 12, 2025

Quick Summary

Objectives: 

Objectives

  • Purpose: Support collaborative research and innovation to develop predictive biomarkers of disease progression and treatment respons...
Eligibility criteria: 
  • Eligible applicants: Any legal entity may participate if it is established in an eligible country under Horizon Europe rules; legal entities established in the United States of America are specifically eligible to receive Union funding.
  • Geographic and legal eligibility: Eligible countries are those listed in the Horizon Europe general annexes. Legal entities established in China are not eligible to participate in this destination. Topics subject to communication-network protection restrictions exclude high-risk suppliers of mobile network equipment...
Share

Similar grants

By Locations
Funding Agency: NGO
Status: open
Location: Ireland, UK
Funding Agency: Government
Status: open
Location: France
By Sectors
Funding Agency: EC, EIB
Status: open
Location: Aruba, Austria, Belgium, Bulgaria, Caribbean Ne...
Funding Agency: Horizon Europe
Status: open
Location: Greece, Italy, Romania, Spain, UK